Cited by 70Alzheimer's disease research and treatmentsTraumatic Brain Injury and Neurovascular DisturbancesTraumatic Brain Injury Research

Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer’s disease transgenic mice

Open access
Tajiri, Naoki, Kellogg, S. Leilani, Shimizu, Toru, Arendash, Gary W., Borlongan, Cesar V.·2013·PLoS ONE

Abstract

Traumatic brain injury (TBI) has become a signature wound of the wars in Iraq and Afghanistan. Many American soldiers, even those undiagnosed but likely suffering from mild TBI, display Alzheimer's disease (AD)-like cognitive impairments, suggesting a pathological overlap between TBI and AD. This study examined the cognitive and neurohistological effects of TBI in presymptomatic APP/PS1 AD-transgenic mice. AD mice and non-transgenic (NT) mice received an experimental TBI on the right parietal cortex using the controlled cortical impact model. Animals were trained in a water maze task for spatial memory before TBI, and then reevaluated in the same task at two and six weeks post-TBI. The results showed that AD mice with TBI made significantly more errors in the task than AD mice without TBI and NT mice regardless of TBI. A separate group of AD mice and NT mice were evaluated neurohistologically at six weeks after TBI. The number of extracellular beta-amyloid (Aβ)-deposits significantly increased by at least one fold in the cortex of AD mice that received TBI compared to the NT mice that received TBI or the AD and NT mice that underwent sham surgery. A significant decrease in MAP2 positive cells, indicating neuronal loss, was observed in the cortex of both the AD and NT mice that received TBI compared to the AD and NT mice subjected to sham surgery. Similar changes in extracellular Aβ deposits and MAP2 positive cells were also seen in the hippocampus. These results demonstrate for the first time that TBI precipitates cognitive impairment in presymptomatic AD mice, while also confirming extracellular Aβ deposits following TBI. The recognition of this pathological link between TBI and AD should aid in developing novel treatments directed at abrogating cellular injury and extracellular Aβ deposition in the brain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0078851

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many animal studies show increased production and accumulation of amyloid precursor protein (APP), Aβ, and pathological tau following TBI.

    “Second, many animal studies show increased production and accumulation of amyloid precursor protein (APP), Aβ, and pathological tau following TBI (16, 21–28).”

    From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [24]

    The Results report increased extracellular Aβ deposits after TBI in mice, and the Discussion reports another mouse study finding Aβ accumulation and increased phospho-tau immunoreactivity. The paper does not report increased production or accumulation of APP; its Discussion only proposes increased cleavage of APP to Aβ. It also does not establish the claim across “many” animal studies. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 70

Research works printed but not linked: 35

  1. [1]O'Meara ES, Kukull WA, Sheppard L, Bowen JD, McCormick WC, et al (1997) Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. Am J Epidemiol 146: 373– 384. 9290497
  2. [2]Salib E, Hillier V (1997) Head injury and the risk of Alzheimer's disease: a case control study. Int J Geriatr Psychiatry 12: 363– 368. 9152722
  3. [3]Schofield PW, Tang M, Marder K, Bell K, Dooneief G, et al (1997) Alzheimer's disease after remote head injury: an incidence study. J Neurol Neurosurg Psychiatry 62: 119– 124. 9048710 PMC486721
  4. [4]Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, et al (2000) Head injury and the risk of AD in the MIRAGE study. Neurology 54: 1316– 1323. 10746604
  5. [5]Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, et al (2000) Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55: 1158– 1166. 11071494
  6. [6]Sarmiento K, Langlois JA, Mitchko J (2008) "Help seniors live better, longer: prevent brain injury": an overview of CDC's education initiative to prevent fall-related TBI among older adults. J Head Trauma Rehabil 23: 164– 167. 18520429
  7. [7]Thomas KE, Stevens JA, Sarmiento K, Wald MM (2008) Fall-related traumatic brain injury deaths and hospitalizations among older adults--United States, 2005. J Safety Res 39: 269– 272. 18571567
  8. [8]Roberts GW, Allsop D, Bruton C (1990) The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 53: 373– 378. 2191084 PMC488051
  9. [9]Dale GE, Leigh PN, Luthert P, Anderton BH, Roberts GW (1991) Neurofibrillary tangles in dementia pugilistica are ubiquitinated. J Neurol Neurosurg Psychiatry 54: 116– 118. 1850450 PMC1014344
  10. [10]Omalu BI, DeKosky ST, Minster RL, Kamboh MI, Hamilton RL, et al (2005) Chronic traumatic encephalopathy in a National Football League player. Neurosurgery 57: 128– 134 discussion 128–134. 15987548
  11. [11]Omalu BI, DeKosky ST, Hamilton RL, Minster RL, Kamboh MI, et al (2006) Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery 59: 1086– 1092 discussion 1092–1083. 17143242
  12. [12]McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, et al (2009) Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68: 709– 735. 19535999 PMC2945234
  13. [13]McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, et al (2010) TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 69: 918– 929. 20720505 PMC2951281
  14. [14]Kline RP, Pirraglia E, Cheng H, De Santi S, Li Y, et al (2012) Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment. Anesthesiology 116: 603– 612. 22293721 PMC3418798
  15. [15]Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, et al (2012) Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease. AJNR Am J Neuroradiol 33: 1109– 1114. 22300935 PMC8013247
  16. [16]DeKosky ST, Ikonomovic MD, Gandy S (2010) Traumatic brain injury--football, warfare, and long-term effects. N Engl J Med 363: 1293– 1296. 20879875
  17. [17]Miller G (2011) Neuropathology. A battle no soldier wants to fight. Science 333: 517– 519. 21798910
  18. [18]Forbes ML, Clark RS, Dixon CE, Graham SH, Marion DW, et al (1998) Augmented neuronal death in CA3 hippocampus following hyperventilation early after controlled cortical impact. J Neurosurg 88: 549– 556. 9488311
  19. [19]Shetty AK, Hattiangady B, Rao MS (2009) Vulnerability of hippocampal GABA-ergic interneurons to kainate-induced excitotoxic injury during old age. J Cell Mol Med 13: 2408– 2423. 20141618 PMC2855767
  20. [20]Feng JF, Zhao X, Gurkoff GG, Van KC, Shahlaie K, et al (2012) Post-traumatic hypoxia exacerbates neuronal cell death in the hippocampus. J Neurotrauma 29: 1167– 1179. 22191636 PMC3325587
  21. [21]Tran HT, LaFerla FM, Holtzman DM, Brody DL (2011) Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. J Neurosci 31: 9513– 9525. 21715616 PMC3146343
  22. [22]Paxinos G, Franklin K.B.J (2001) The Mouse Brain in Stereotaxic Coordinates: Hard Cover Edition: Academic press.
  23. [23]Yu S, Kaneko Y, Bae E, Stahl CE, Wang Y, et al (2009) Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res 1287: 157– 163. 19573519
  24. [25]Baldauf K, Reymann KG (2005) Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res 1056: 158– 167. 16125154
  25. [26]Davies TA, Long HJ, Eisenhauer PB, Hastey R, Cribbs DH, et al (2000) Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system. Amyloid 7: 153– 165. 11019856
  26. [27]Mlekusch R, Humpel C (2009) Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels. Neurosci Lett 466: 135– 138. 19786072 PMC4311377
  27. [28]Palmer JC, Kehoe PG, Love S (2010) Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia. Neuropathol Appl Neurobiol 36: 487– 497. 20345647
  28. [29]Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, et al (2003) Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res 25: 665– 674. 14503022
  29. [30]Jantaratnotai N, Ryu JK, Schwab C, McGeer PL, McLarnon JG (2011) Comparison of Vascular Perturbations in an Abeta-Injected Animal Model and in AD Brain. Int J Alzheimers Dis 2011: 918280. 21969915 PMC3182764
  30. [31]Borroni B, Akkawi N, Martini G, Colciaghi F, Prometti P, et al (2002) Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci 203–204: 189– 193. 12417382
  31. [32]Walker DG, Dalsing-Hernandez JE, Lue LF (2008) Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease. Microvasc Res 75: 411– 419. 18048067 PMC2774213
  32. [33]Yesil Y, Kuyumcu ME, Cankurtaran M, Uz B, Kara A, et al (2012) Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD). Arch Gerontol Geriatr 55: 257– 260. 22019010
  33. [34]Pettus EH, Wright DW, Stein DG, Hoffman SW (2005) Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049: 112– 119. 15932748
  34. [35]You Z, Yang J, Takahashi K, Yager PH, Kim HH, et al (2007) Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4. J Cereb Blood Flow Metab 27: 1954– 1964. 17457366
  35. [37]Bryan C, Hernandez AM (2012) Magnitudes of decline on Automated Neuropsychological Assessment Metrics subtest scores relative to predeployment baseline performance among service members evaluated for traumatic brain injury in Iraq. J Head Trauma Rehabil 27: 45– 54. 22218202

Authors
Tajiri, N., Kellogg, S. L., Shimizu, T., Arendash, G. W., & Borlongan, C. V.
Affiliations
  • University of South Florida (US)
  • NeuroEM Therapeutics (United States) (US)
Corresponding author
Borlongan, Cesar V.
Venue
PLoS ONE
Published
2013-11-04
Volume
8
Issue
11
Pages
e78851
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2069828825
Cited by
70
References
37
Citations by year
2025: 1 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 10 · 2016: 8 · 2015: 13 · 2014: 3 · 2013: 1
FWCI
5.80
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Celgene
  • University of South Florida
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS071956, U01NS055914)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
Keywords
traumatic brain injury, Alzheimer's disease, cognitive impairment, amyloid-beta deposition, APP/PS1 mice, controlled cortical impact, spatial memory, neuronal loss, MAP2, hippocampus, parietal cortex
MeSH terms
Alzheimer Disease, Animals, Brain Injuries, Cognition Disorders, Disease Models, Animal, Extracellular Space, Hippocampus, Humans, Memory, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Transgenic, Parietal Lobe, Time Factors, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microscopy, Confocal, Maze Learning, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review